Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,272 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

NCT02636036

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +21 more
Locations
  • University of Arizona Cancer Center, 1515 North Campbell Ave. Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center, 1500 E Duarte Str. Duarte, California, United States
  • UCLA Medical Center, 10945 Le Conte Ave, Ste. 3360 Santa Monica, California, United States
  • Horizon Oncology Research, 1345 Unity Place, Suite 365 Lafayette, Indiana, United States
View Trial Details
Completed

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

NCT00013871

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +38 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 40 locations
View Trial Details
Completed

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

NCT00297596

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Graves-Gilbert Clinic Bowling Green, Kentucky, United States
  • Hematology Oncology Life Center Alexandria, Louisiana, United States
  • Baton Rouge General Medical Center Baton Rouge, Louisiana, United States
  • Oncology Hematology Care Cincinnati, Ohio, United States
View Trial Details
Completed

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

NCT00134056

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
View all 554 locations
View Trial Details
Completed

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

NCT00369785

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +37 more
Locations
  • Associates in Womens Health, PA - North Review Wichita, Kansas, United States
  • Cancer Center of Kansas, PA - Medical Arts Tower Wichita, Kansas, United States
  • Cancer Center of Kansas, PA - Wichita Wichita, Kansas, United States
  • CCOP - Wichita Wichita, Kansas, United States
View all 16 locations
View Trial Details
Completed

Improving Informed Consent for Palliative Chemotherapy

NCT02282722

Conditions
Behavior, Colonic Diseases, Colorectal Neoplasms, +21 more
Locations
  • University of California at San Francisco San Francisco, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber at Milford Milford, Massachusetts, United States
View Trial Details
Completed

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

NCT02115542

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +15 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
View Trial Details
Completed

Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03489343

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

Post-Marketing Surveillance of Lenvima in Korean Patients

NCT02764554

Conditions
Differentiated Thyroid Carcinoma (DTC), Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Eisai Trial Site #18 Anyang, Gyeongji-do, South Korea
  • Eisai Trial Site #30 Bundang, Gyeongji-do, South Korea
  • Eisai Trial Site #14 Goyang, Gyeongji-do, South Korea
  • Eisai Trial Site #27 Goyang, Gyeongji-do, South Korea
View all 32 locations
View Trial Details

Related conditions